Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on IPSEN mainly cover M&A activity, analyst notes et earnings publications. The stock trades at €157,60 on Euronext Paris, up 1,16% at the last update. This page lists the articles published on IPSEN stock to track the share price, company announcements and any item likely to influence market perception.
Ipsen published on October 22, 2026 revenue of 3,364.2 million euros over the first nine months of the year, up 24.6% at constant exchange rates. The …
The Parisian biopharmaceutical laboratory resumes its downward trend in a declining Paris market. A London research firm has recently hardened its vie…
The Parisian biopharmaceutical laboratory is recovering in mid-morning trading, while the Paris market remains oriented downward. The rebound occurs a…
The Parisian biopharmaceutical company rebounds in early afternoon trading, amid a declining Paris market. The move follows a breach of a closely moni…
Pressure continues to mount on the Paris-based biopharmaceutical laboratory. Four days after U.S. authorization of a generic version of lanreotide, th…
Ipsen shares fall more than 7% Monday morning on the Paris Stock Exchange following US authorization of a generic version of lanreotide, the active in…
The co-optation takes effect immediately and follows the resignation of Michèle Ollier on August 1, 2026. It will be subject to ratification at the ne…
The share of the Parisian biopharmaceutical laboratory is among the most penalized values of the broader index this Thursday, in an otherwise slightly…
The Parisian biopharmaceutical laboratory experienced its worst session of the index on Tuesday morning, driven by a surprise downgrade from Barclays …
The biopharmaceutical laboratory's share is declining sharply at the end of the week, while the SBF 120 remains nearly stable during the session. This…
